El Molecular diagnostics in Spain has many names in our country: Symposium Biopsy Liquid, on this occasion celebrates its sixth edition. A quote from the principal experts in the subject will cover the latest innovations that will make the state of these new technologies.
The front of this enclosure will be a mesa redonda que abordará exactly the inclusion of biomarkers to follow advancing in precision medicine. Precisely, the previous edition of this letter about the month of the need to include a biomarker card in the National Health System (SNS).
Oncologists val saam as it is a fundamental premise for advancing in cancer. The Mesa about biomarkers tend to be this Monday 25 and will meet with the participation of the coordinator of the Symposium and the head of the Oncology Service of the Clinical University of Santiago de Compostela Hospital, Rafael López, the head of the Oncology Foundation IVO, Vicente Guillem, and the President of SEOM, Álvaro Rodríguez Lescure. Asimismo, the session will contrast with the statements of the representatives of Astrazéneca and Lilly, Guillem Bruch and José Mª Cervera respectively, who will present the latest innovations in material of biomarkers generated in his laboratories.
In the same way, advances made by the Molecular Diagnostic Campus will be quoted from 28 to 28 January. What is the clinical reality of liquid biopsy in different tumors? The experts will discuss the same mode, the new horizons for its application. Además, put the focus on epigenetics in liquid biopsy; his translation in tumors as the mother’s cancer; or agnostic therapies.
Definitely, the liquid biopsy to guide the immunotherapy and the potential of the directive therapies will also be a fundamental part of this encounter.
GM will provide a special cover for this enclosure.